Lansoprazole
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171906This classification denotes a proton pump inhibitor with the molecular formula C16H14F3N3O2S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 0K5C5T2QPG, chemically known as 2-(((3-methyl-4-(2,2,2-trifluoroethoxy)-2-pyridyl)methyl)sulfinyl)benzimidazole but generally known as lansoprazole, which bears US NIH Compound Identifier 3883. European Medicines Agency schedules Lansoprazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08403MIG. The term LANSOPRAZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, No. 3, 1989, List 29). World Health Organization schedules lansoprazole in its Anatomical Therapeutic Chemical (ATC) Classification. LANSOPRAZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule lansoprazole under HS 29333999 and SITC 51574. As of Q4 2014, LANSOPRAZOLE remains the US FDA Preferred Term for this commodity. Lansoprazole bears US NLM identifiers UMLS ID C0286036 and NCI Concept Code C29150. SMILES: S(=O)(CC1NCCC(OCC(F)(F)F)C1C)C1[NH]C2C(N1)CCCC2.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.